InterMune's Series A Round

InterMune raised a round of funding on October 01, 1998.

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. In pulmonology, the company is foc…

Articles about InterMune's Series A Round: